JXYM Annual Report 2020

Greetings from Dr. Jianzhong Hu, Dr. Paul Schoenhagen and Editorial Office of Journal of Xiangya Medicine (JXYM)!

We are glad to present the 2020 Annual Report of JXYM here. In 2020, JXYM has published 43 articles, among which there are 12 original articles, 6 review articles. 105 Editorial Board Members from 23 countries joined us since its launch. More information is shown in the Annual Report.

We would like to express our sincere gratitude to the editorial board members, guest editors, authors, reviewers and readers for all your support and contributions to JXYM. In the new year, we warmly welcome more excellent surgeons and researchers to join us to make JXYM an innovative and significant platform.

Read More>>

Malignant Pleural Effusion

Malignant pleural effusions are a serious complication of advanced cancer and are often associated with a poor prognosis. A quick diagnostic phase is therefore essential. Imaging techniques allow us to accurately establish the extent of the pleural effusion but not its nature.

Read More>>

De Winter sign associated with roes-induced anaphylactic shock: a new electrocardiographic manifestation of Kounis syndrome

A 44-year-old male patient, smoker (a pack per day for 10 years), with history of hypersensitivity, was presented with skin pruritus after eating roes for an hour, and shortness of breath, no response to command for half an hour. His blood pressure was undetectable. Diffuse erythema was all over the body. No rales were found in the lungs. His heart rate was 115 beats per minute, and the heart rhythm was regular. The heart sound was weak, and no murmur was heard.

Read More>>

Diagnosis and management of free-floating filling defect in carotid artery—a case report

A 56 years old male admitted because of transient amaurosis fugax for 1 month. Ultrasonography found >90% carotid artery stenosis with free-floating filling defect in carotid artery for 4 days. The patient has a history of hypertension for 20 years and hyperlipidemia for 16 years. Four years ago, the patient has suffered from right stroke and recovered without sequelae.

Read More>>

Effects of COVID-19 on the cardiovascular system and implications for management

Coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus-2 is now a global pandemic. First reported as causing pneumonia, with acute respiratory distress syndrome and multiorgan dysfunction in severe cases, more data is becoming available on the extra-pulmonary manifestations of the disease. This article discusses the cardiovascular effects of COVID-19, the possible mechanisms of injury to the cardiovascular system and the implications for management.

Read More>>

High-resolution chest CT angiography of patients with COVID-19 pneumonia: a longitudinal prospective study

Out of the 36 patients referred to the Covid Center, 30.6% (11/36) were admitted to the intensive care unit (ICU) and 69.4% (25/36) to the non-ICU low-cure Covid Medicine. A significant inverse relationship was found between the P/F ratio and lung lesion volume relative percentages (r=–0.52; 95% CI: –0.72, –0.23; P=0.001), absolute volume (r=–0.58; 95% CI: –0.76, –0.31; P<0.001) and the CT severity score (r=–0.60; 95% CI: –0.77, –0.34; P<0.001) at day 0. At day 7, CT angiography (CTA) showed pulmonary embolism in 2/10 patients (20%). In 9/10 patients (90%) CTA detected vascular wall thickening/irregularity and stenoses of segmental and/or subsegmental branches of pulmonary artery. CTA demonstrated subsegmental tubular vessel dilation in all cases (100%) and the presence of subsegmental focal vessel dilations in 6/10 patients (60%).

Read More>>

COVID-19 and the cardiovascular system: a systematic review of the clinical trial landscape

A search on ClinicalTrials.gov produced a variety of studies that investigate relationships between COVID-19 and the CV system. The search identified the main areas with ongoing research that has the ability to resolve controversies regarding current management of patients with COVID-19 including the ideal thromboprophylaxis regimen; arrhythmogenic potential of patients with COVID-19 and appropriate monitoring of these patients and long term morbidity related to COVID-19 and the CV system. The key finding of this analysis is that the majority of the ongoing studies are observational in nature and not randomized controlled trials.

Read More>>